Abstract
A defective, mutated androgen receptor may lead to variable phenotypes of androgen insensitivity in humans. Also, the CAG repeat polymorphism in exon 1 of the androgen receptor gene modulates androgen effects; in vitro, transcription of androgen-dependent target genes is attenuated with increasing length of triplet residues. Clinically, the CAG repeat polymorphism causes significant modulations of androgenicity in various tissues and psychological traits in healthy eugonadal men: the longer the repeat tracts, the less pronounced is the androgen effect when individuals with similar testosterone concentrations are compared. Furthermore, as effects of testosterone substitution are markedly influenced by the number of CAG repeats, the pharmacogenetic implications of this polymorphism are likely to have a significant role in future testosterone treatment of hypogonadal men. Thresholds at which testosterone treatment should be initiated, as well as androgen dosage, might be tailored according to the receptor polymorphism.
Key Points
-
The CAG repeat polymorphism in exon 1 of the androgen receptor gene modulates androgen effects
-
In vitro, transcription of androgen-dependent target genes is attenuated with increasing length of triplet residues
-
Clinically, the CAG repeat polymorphism causes significant modulations of androgenicity in healthy eugonadal men in various tissues and is associated with different psychological traits; the longer the repeat tracts, the less pronounced is the androgen effect when individuals with similar testosterone concentrations are compared
-
Effects of testosterone substitution are markedly influenced by the number of CAG repeats in retrospective studies
-
The pharmacogenetic implications of this polymorphism are likely to have a significant role in future testosterone treatment of hypogonadal men as initiation thresholds of testosterone treatment and androgen dose might be tailored according to an individual's receptor polymorphism
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kelleher S et al. (2004) Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 89: 3813–3817
Chang C et al. (1988) Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci USA 85: 7211–7215
Quigley CA et al. (1995) Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16: 271–321
Heinlein CA and Chang C (2002) Androgen receptor (AR) coregulators: an overview. Endocr Rev 23: 175–200
Hiort O et al. (1996) The clinical and molecular spectrum of androgen insensitivity. Am J Med Genet 63: 218–222
Meschede D et al. (2000) Disorders of androgen target organs. In: Andrology: male reproductive health and dysfunction, edn 2, 223–229 (Eds Nieschlag E and Behre HM) Heidelberg: Springer
La Spada AR et al. (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352: 77–79
Hsiao PW et al. (1999) The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator. J Biol Chem 274: 20229–20234
Irvine RA et al. (2002) Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Gen 9: 267–274
Zitzmann M et al. (2001) The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J Clin Endocrinol Metab 86: 4867–4873
Zitzmann M et al. (2001) The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males. Clin Endocrinol (Oxf) 55: 649–657
Zitzmann M et al. (2003) The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia 46: 31–39
Yaffe K et al. (2003) Androgen receptor CAG repeat polymorphism is associated with cognitive function in older men. Biol Psychiatry 54: 943–946
Walsh S et al. (2005) Androgen receptor CAG repeat polymorphism is associated with fat-free mass in men. J Appl Physiol 98: 132–137
Seidman SN et al. (2001) Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men. Biol Psychiatry 50: 371–376
Zitzmann M and Nieschlag E (2003) The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl 26: 76–83
Canale D et al. (2005) Androgen receptor polymorphism (CAG repeats) and androgenicity. Clin Endocrinol (Oxf) 63: 356–361
Zitzmann M et al. (2004) X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. J Clin Endocrinol Metab 89: 6208–6217
Zinn AR et al. (2005) Androgen receptor CAGn repeat length influences phenotype of 47, XXY (Klinefelter) syndrome. J Clin Endocrinol Metab 90: 5041–5046
Wikstrom AM et al. (2006) Genetic features of the X chromosome affect pubertal development and testicular degeneration in adolescent boys with Klinefelter syndrome. Clin Endocrinol (Oxf) 65: 92–97
Albertelli MA et al. (2006) Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice. Mol Endocrinol 20: 1248–1260
Coutinho-Camillo CM et al. (2006) Identification of differentially expressed genes in prostatic epithelium in relation to androgen receptor CAG repeat length. Int J Biol Markers 21: 96–105
Zeegers MP et al. (2004) How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiol Biomarkers Prev 13: 1765–1771
Giovannucci E et al. (1999) CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in US physicians. Prostate 39: 130–134
Giovannucci E et al. (1999) The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia. Urology 53: 121–125
Mitsumori K et al. (1999) Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth. Prostate 41: 253–257
Jin B et al. (2000) Androgen receptor gene polymorphism and prostate zonal volumes in Australian and Chinese men. J Androl 21: 91–98
Zitzmann M et al. (2003) Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic study. J Clin Endocrinol Metab 88: 2049–2054
von Eckardstein S et al. (2001) Inverse correlation between sperm concentration and number of androgen receptor CAG repeats in normal men. J Clin Endocrinol Metab 86: 2585–2590
Yu B and Handelsman DJ (2001) Pharmacogenetic polymorphisms of the AR and metabolism and susceptibility to hormone-induced azoospermia. J Clin Endocrinol Metab 86: 4406–4411
Wakisaka N et al. (2005) Effectiveness of finasteride on patients with male pattern baldness who have different androgen receptor gene polymorphism. J Investig Dermatol Symp Proc 10: 293–294
Bhasin S et al. (2001) Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 281: 1172–1181
Page ST et al. (2006) The androgen receptor gene CAG repeat polymorphism does not predict increased risk of heart disease: longitudinal results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 65: 333–339
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Zitzmann, M. Mechanisms of Disease: pharmacogenetics of testosterone therapy in hypogonadal men. Nat Rev Urol 4, 161–166 (2007). https://doi.org/10.1038/ncpuro0706
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0706
This article is cited by
-
Safety of gender affirming treatment in assigned female at birth transgender people and association of androgen and estrogen β receptor polymorphisms with clinical outcomes
Endocrine (2023)
-
Repeat length variations in polyglutamine disease-associated genes affect body mass index
International Journal of Obesity (2019)
-
Hypotestosteronemia is an important factor for the development of hypertension: elevated blood pressure in orchidectomized conscious rats is reversed by different androgens
Endocrine (2019)
-
Mannelijk hypogonadisme, een update
Tijdschrift voor Urologie (2018)
-
Tipps zur richtigen Testosteronbestimmung und -diagnostik
Uro-News (2017)